SLK-Kliniken Heilbronn

Recent papers from SLK-Kliniken Heilbronn

1. Two cases of an imatinib-sensitive PRKG2::PDGFRA-positive chronic myeloid neoplasm with basophiliaLeukemia · 2026
2. Competition in Building Heating—The Techno-Economic Case for Decentralized Heat Pumps in Germany up to 2045Energies · 2026
3. Results from the Pan-European CIEMAR study: Local Tumour Control After Microwave Ablation of Colorectal Liver Metastases and Exploratory Associations with Ablation Margins and Confirmation SoftwareCardioVascular and Interventional Radiology · 2026
4. Management of postpartum hemorrhage at a level 1 perinatal centerDie Anaesthesiologie · 2026
5. Evaluation of an iterative motion-correction algorithm for hepatic cone-beam CT during transarterial interventionsEuropean Journal of Radiology · 2026
6. Aortic pseudoaneurysm caused by Tempofilter II inferior vena cava filter strut perforation: a case reportFrontiers in Surgery · 2026
7. NUP153 immunoreactivity in neuroendocrine neoplasms supports the diagnosis of NET versus NEC and is modulated by post‐translational modificationsJournal of Neuroendocrinology · 2026
8. Association of Diabetes Mellitus and Obesity with Early Complications After Surgical Tracheostomy in Critically Ill ICU Patients: A Retrospective Observational Cohort StudyLife · 2026
9. Effectiveness and safety of enfortumab vedotin and pembrolizumab in a real-world patient population with urothelial carcinoma: results from a multi-institutional cohort (GUARDIANS)Cancer Immunology Immunotherapy · 2026
10. Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung CancerJAMA Oncology · 2026
11. Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP InhibitorsJAMA Oncology · 2026
12. Constitutional BRCA1 Promoter Methylation in Patients With Ovarian Cancer: Results of the Observational AGO-TR1 StudyJCO Precision Oncology · 2026
13. Intrathecal nivolumab in metastatic solid tumors with leptomeningeal disease: dose escalation part of the multicenter IT-PD1/NOA-26 phase 1 trialNature Cancer · 2026
14. Chemotherapy for patients with circulating tumour DNA positive, stage II colon cancer (CIRCULATE) – an AIO / ABCSG trialAnnals of Oncology · 2026
15. Tumor ablation: emerging uses, challenges, and strategic implementation. A green paper by the Network of Expertise in Cancer (JANE-2), High Tech Medical Resources, network on Physical Methods of Tumor AblationRadiology and Oncology · 2026
16. Radiomics-based outcome prediction for irinotecan-TACE in colorectal liver metastases: advanced analysis from the prospective CIREL trial.2026
17. Minimal Residual Disease Assessment Through ctDNA Facilitates Tailored Immunotherapy in MSI-High, NTRK1-Fusion Pancreatic AdenocarcinomaThe Oncologist · 2026
18. State-of-the-Art Definitive Femoropopliteal Lesion Treatment: A Case-Based Systematic ApproachJournal of Cardiovascular Development and Disease · 2026
19. Skin physiology during daylight photodynamic therapy with additional fractional laser therapyEuropean Journal of Dermatology · 2026
20. Neue Arbeitswelten gestalten: Wie die Stadtbibliothek Heilbronn New Work erfolgreich umgesetzt hatBIBLIOTHEK Forschung und Praxis · 2026